Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP)
Abstract Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from vaccine preventable diseases. At the request of its European Technical Advisory Group of Experts on Immunization (ETAGE), the Vaccine-preventa...
Saved in:
Published in | Vaccine Vol. 33; no. 34; pp. 4176 - 4179 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
14.08.2015
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from vaccine preventable diseases. At the request of its European Technical Advisory Group of Experts on Immunization (ETAGE), the Vaccine-preventable Diseases and Immunization Programme of the WHO Regional Office for Europe (WHO/EURO) developed tools to help countries address hesitancy more effectively. The Guide to Tailoring Immunization Programmes (TIP), an evidence and theory based behavioral insight framework, issued in 2013, provides tools to (1) identify vaccine hesitant population subgroups, (2) diagnose their demand- and supply-side immunization barriers and enablers and (3) design evidence-informed responses to hesitancy appropriate to the subgroup setting, context and vaccine. The Strategic Advisory Group of Experts on Immunization (SAGE) through its Working Group on Vaccine Hesitancy has closely followed the development, implementation, use and evolution of TIP concluding that TIP, with local adaptation, could be a valuable tool for use in all WHO regions, to help address countries’ vaccine hesitancy problems. The TIP principles are applicable to communicable, noncommunicable and emergency planning where behavioral decisions influence outcomes. |
---|---|
AbstractList | Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from vaccine preventable diseases. At the request of its European Technical Advisory Group of Experts on Immunization (ETAGE), the Vaccine-preventable Diseases and Immunization Programme of the WHO Regional Office for Europe (WHO/EURO) developed tools to help countries address hesitancy more effectively. The Guide to Tailoring Immunization Programmes (TIP), an evidence and theory based behavioral insight framework, issued in 2013, provides tools to (1) identify vaccine hesitant population subgroups, (2) diagnose their demand- and supply-side immunization barriers and enablers and (3) design evidence-informed responses to hesitancy appropriate to the subgroup setting, context and vaccine. The Strategic Advisory Group of Experts on Immunization (SAGE) through its Working Group on Vaccine Hesitancy has closely followed the development, implementation, use and evolution of TIP concluding that TIP, with local adaptation, could be a valuable tool for use in all WHO regions, to help address countries' vaccine hesitancy problems. The TIP principles are applicable to communicable, noncommunicable and emergency planning where behavioral decisions influence outcomes. Abstract Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from vaccine preventable diseases. At the request of its European Technical Advisory Group of Experts on Immunization (ETAGE), the Vaccine-preventable Diseases and Immunization Programme of the WHO Regional Office for Europe (WHO/EURO) developed tools to help countries address hesitancy more effectively. The Guide to Tailoring Immunization Programmes (TIP), an evidence and theory based behavioral insight framework, issued in 2013, provides tools to (1) identify vaccine hesitant population subgroups, (2) diagnose their demand- and supply-side immunization barriers and enablers and (3) design evidence-informed responses to hesitancy appropriate to the subgroup setting, context and vaccine. The Strategic Advisory Group of Experts on Immunization (SAGE) through its Working Group on Vaccine Hesitancy has closely followed the development, implementation, use and evolution of TIP concluding that TIP, with local adaptation, could be a valuable tool for use in all WHO regions, to help address countries’ vaccine hesitancy problems. The TIP principles are applicable to communicable, noncommunicable and emergency planning where behavioral decisions influence outcomes. |
Author | Butler, Robb MacDonald, Noni E |
Author_xml | – sequence: 1 fullname: Butler, Robb – sequence: 2 fullname: MacDonald, Noni E |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25896376$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl9rFDEUxYNU7Lb6EZSAL_VhxvyZSTI-KFK1LhQsuIJvIZu5s806k6zJTGHFD2-GXRX6ok_Jw--cy73nnKETHzwg9JSSkhIqXm7LO2Ot81AyQuuSVCXh6gFaUCV5wWqqTtCCMFEVFSVfT9FZSltCSM1p8widslo1gkuxQD_fObPxITm_weMt4BZGiIPzxo8Jhw4fh-BbSG403u6x8zjtwLrOWZym9SaGaZde4VUWX02uBTwGvDKuD3H2XA7D5N0PM7rg8U0Mm2iGARK-WC1vXjxGDzvTJ3hyfM_Rlw_vV5cfi-tPV8vLt9eFrRs1FrxjjFSmoUrV3DaK0Ja0-Vd1NQhooVW86njDG7tmQjS2q4WUtjXMWMFAVvwcXRx8dzF8nyCNenDJQt8bD2FKmkrKpCSyUf-BEsGIZIJl9Pk9dBum6PMiM6Uob_K1M1UfKBtDShE6vYtuMHGvKdFzknqrj0fWc5KaVDonmXXPju7TeoD2j-p3dBl4cwAgX-7OQdTJOvAWWhfBjroN7p8jXt9zsL3zzpr-G-wh_d1GJ6aJ_jzXaW4TrXORCGP8F1a0yGY |
CitedBy_id | crossref_primary_10_1186_s13643_018_0692_y crossref_primary_10_1007_s10865_022_00321_6 crossref_primary_10_1016_j_vaccine_2020_09_022 crossref_primary_10_18231_j_ijfcm_2021_045 crossref_primary_10_2807_1560_7917_ES_2022_27_18_2100615 crossref_primary_10_18553_jmcp_2022_28_2_196 crossref_primary_10_3390_vaccines11020223 crossref_primary_10_1016_j_vaccine_2019_07_079 crossref_primary_10_3390_ijerph17165893 crossref_primary_10_1016_j_jvacx_2024_100507 crossref_primary_10_1016_j_vaccine_2019_11_056 crossref_primary_10_1038_s41598_023_50756_3 crossref_primary_10_1080_10810730_2020_1868630 crossref_primary_10_1371_journal_pone_0268926 crossref_primary_10_1016_j_vaccine_2023_08_063 crossref_primary_10_1016_j_vaccine_2015_11_051 crossref_primary_10_1108_JSOCM_10_2020_0206 crossref_primary_10_1136_bmjopen_2022_067169 crossref_primary_10_1108_GKMC_07_2023_0244 crossref_primary_10_1016_j_cct_2023_107403 crossref_primary_10_26633_RPSP_2019_54 crossref_primary_10_3389_fpubh_2022_871015 crossref_primary_10_1016_j_jvacx_2023_100351 crossref_primary_10_1093_ofid_ofx146 crossref_primary_10_1080_14760584_2018_1541406 crossref_primary_10_3390_vaccines8040582 crossref_primary_10_1097_INF_0000000000001321 crossref_primary_10_1371_journal_pone_0237171 crossref_primary_10_3390_vaccines9121437 crossref_primary_10_1155_2024_4098357 crossref_primary_10_2196_30642 crossref_primary_10_2147_IDR_S316461 crossref_primary_10_1007_s00103_019_02900_6 crossref_primary_10_1016_j_lana_2021_100055 crossref_primary_10_1016_S1473_3099_16_00028_1 crossref_primary_10_1177_17504813211043724 crossref_primary_10_1371_journal_pntd_0012060 crossref_primary_10_1080_1369118X_2017_1418406 crossref_primary_10_3389_fpubh_2021_665724 crossref_primary_10_1177_00178969221092135 crossref_primary_10_3390_ijerph18126469 crossref_primary_10_1007_s12098_017_2532_9 crossref_primary_10_1177_0033354920974660 crossref_primary_10_1093_heapro_daac116 crossref_primary_10_1016_j_pvr_2017_02_004 crossref_primary_10_1016_j_puhip_2022_100305 crossref_primary_10_1016_j_jpedp_2018_05_006 crossref_primary_10_3390_vaccines10010007 crossref_primary_10_1038_s41598_024_56116_z crossref_primary_10_1007_s40271_024_00687_6 crossref_primary_10_3390_vaccines11121736 crossref_primary_10_1007_s40121_020_00302_9 crossref_primary_10_3390_vaccines9070777 crossref_primary_10_3390_joitmc6040132 crossref_primary_10_1016_j_vaccine_2023_02_081 crossref_primary_10_1371_journal_pone_0302332 crossref_primary_10_1057_s41599_023_01593_2 crossref_primary_10_1177_14034948221144661 crossref_primary_10_1177_1715163519878745 crossref_primary_10_1371_journal_pone_0284810 crossref_primary_10_1080_21645515_2021_2004837 crossref_primary_10_1080_10410236_2021_1973702 crossref_primary_10_1177_2372732215600716 crossref_primary_10_1017_dmp_2023_83 crossref_primary_10_1093_heapro_daad053 crossref_primary_10_1097_pq9_0000000000000643 crossref_primary_10_1016_j_jen_2020_09_003 crossref_primary_10_1016_j_puhe_2019_04_008 crossref_primary_10_1016_j_vaccine_2021_06_080 crossref_primary_10_1080_08824096_2023_2279964 crossref_primary_10_1371_journal_pone_0268587 crossref_primary_10_3390_healthcare11040461 crossref_primary_10_1186_s12889_020_09815_x crossref_primary_10_3390_pharmacy11020046 crossref_primary_10_1136_bmjgh_2021_005525 crossref_primary_10_12968_jpar_2022_14_3_94 crossref_primary_10_1016_j_vaccine_2019_03_041 crossref_primary_10_1177_1359105316639440 crossref_primary_10_1007_s10865_022_00324_3 crossref_primary_10_1016_j_jped_2018_01_008 crossref_primary_10_1016_j_gaceta_2017_07_004 crossref_primary_10_1016_j_vaccine_2018_12_042 crossref_primary_10_1186_s12889_022_13536_8 crossref_primary_10_1080_21645515_2019_1609823 crossref_primary_10_3390_vaccines9101100 crossref_primary_10_1001_jamanetworkopen_2022_20391 crossref_primary_10_1136_bmjgh_2020_004004 crossref_primary_10_4103_jehp_jehp_1376_22 crossref_primary_10_1016_j_vaccine_2017_09_075 crossref_primary_10_1080_21645515_2022_2062972 crossref_primary_10_1111_ene_15368 crossref_primary_10_21101_cejph_a7074 crossref_primary_10_1371_journal_pone_0257237 crossref_primary_10_2807_1560_7917_ES_2016_21_9_30152 crossref_primary_10_1590_0102_311xen165023 crossref_primary_10_1093_heapro_daaa011 crossref_primary_10_1371_journal_pone_0282520 crossref_primary_10_1016_j_ajic_2024_05_008 crossref_primary_10_1017_S0033291721001434 crossref_primary_10_51847_KhNTSEqJwK crossref_primary_10_3390_vaccines11061052 crossref_primary_10_3390_jcm10071428 crossref_primary_10_1016_j_vaccine_2018_03_063 crossref_primary_10_3389_fpubh_2022_1012822 crossref_primary_10_1002_jmv_27255 crossref_primary_10_1186_s12919_023_00264_z crossref_primary_10_1136_bmjopen_2023_073172 crossref_primary_10_1080_21645515_2019_1640556 crossref_primary_10_1002_hpja_691 crossref_primary_10_1371_journal_pone_0259381 crossref_primary_10_1038_s41432_021_0178_y crossref_primary_10_3390_vaccines9060566 crossref_primary_10_1016_j_vaccine_2022_09_093 crossref_primary_10_1371_journal_pone_0266003 crossref_primary_10_1007_s43039_022_00049_w crossref_primary_10_1098_rsif_2021_0435 crossref_primary_10_1016_j_vaccine_2018_03_052 crossref_primary_10_3390_vaccines10010060 crossref_primary_10_1371_journal_pone_0278332 crossref_primary_10_1016_j_jvacx_2022_100213 crossref_primary_10_36106_ijsr_1302614 crossref_primary_10_1186_s12889_019_7309_9 crossref_primary_10_1002_nop2_1438 crossref_primary_10_1016_j_vaccine_2015_04_039 crossref_primary_10_1016_j_vaccine_2017_12_019 crossref_primary_10_1016_j_jtumed_2022_11_007 crossref_primary_10_1080_22423982_2023_2252604 crossref_primary_10_1016_j_vaccine_2024_04_031 crossref_primary_10_1016_j_vaccine_2015_04_035 crossref_primary_10_1155_2019_8732191 crossref_primary_10_1016_j_vaccine_2015_04_043 crossref_primary_10_1136_bmjopen_2022_070843 crossref_primary_10_2807_1560_7917_ES_2024_29_9_2300276 crossref_primary_10_1016_j_vaccine_2015_04_042 crossref_primary_10_1016_j_gaceta_2023_102329 crossref_primary_10_1186_s12889_024_18713_5 crossref_primary_10_3390_vaccines10101640 crossref_primary_10_1016_j_vaccine_2017_08_064 crossref_primary_10_3390_ijerph18157859 crossref_primary_10_34084_bshr_1119703 crossref_primary_10_1016_j_compbiomed_2021_104957 crossref_primary_10_12677_ASS_2021_1011429 crossref_primary_10_1016_j_vaccine_2022_08_044 crossref_primary_10_1080_21645515_2017_1394533 crossref_primary_10_3390_vaccines11081323 crossref_primary_10_1186_s40249_022_01047_y crossref_primary_10_1016_j_jvacx_2022_100207 crossref_primary_10_3390_ijerph15112428 crossref_primary_10_17116_profmed20212402197 crossref_primary_10_1016_j_vaccine_2018_03_072 crossref_primary_10_1111_1753_6405_12720 crossref_primary_10_1016_j_ajic_2022_07_001 crossref_primary_10_2196_38418 crossref_primary_10_3310_hta20720 crossref_primary_10_4081_jphia_2023_2393 crossref_primary_10_1007_s10067_020_05059_7 crossref_primary_10_3389_frhs_2022_897227 crossref_primary_10_54751_revistafoco_v16n5_107 crossref_primary_10_3390_vaccines9121384 crossref_primary_10_1016_j_vaccine_2017_08_078 crossref_primary_10_7759_cureus_41070 crossref_primary_10_1371_journal_pone_0266670 crossref_primary_10_3389_fmed_2022_877764 crossref_primary_10_1016_j_ijnurstu_2022_104241 crossref_primary_10_3389_fpubh_2024_1408871 crossref_primary_10_1186_s12889_022_13236_3 crossref_primary_10_1038_s41467_022_34995_y crossref_primary_10_32481_djph_2021_022 crossref_primary_10_7189_jogh_11_05027 crossref_primary_10_1177_23333928221098903 crossref_primary_10_1017_S0950268819000517 crossref_primary_10_1080_14760584_2020_1775080 crossref_primary_10_1016_j_vaccine_2018_07_046 crossref_primary_10_3390_vaccines10122096 crossref_primary_10_1016_j_ssmph_2023_101517 crossref_primary_10_3389_fpubh_2023_1192676 crossref_primary_10_1177_13591053221089104 crossref_primary_10_1016_j_ajic_2016_10_009 crossref_primary_10_1371_journal_pone_0208601 crossref_primary_10_1016_j_vaccine_2023_02_059 crossref_primary_10_1016_S1473_3099_21_00193_6 crossref_primary_10_1080_21645515_2019_1572409 crossref_primary_10_1016_j_jmir_2022_11_012 crossref_primary_10_1016_j_vaccine_2022_12_065 crossref_primary_10_1016_j_psychres_2021_114329 crossref_primary_10_1371_journal_pone_0175883 crossref_primary_10_3390_vaccines11020488 crossref_primary_10_1016_j_vaccine_2023_03_061 crossref_primary_10_1080_21645515_2018_1522921 crossref_primary_10_1016_j_vaccine_2015_12_008 crossref_primary_10_1111_inr_12762 crossref_primary_10_1016_j_vaccine_2019_09_020 crossref_primary_10_1080_21645515_2019_1603563 crossref_primary_10_1016_j_socscimed_2023_115779 crossref_primary_10_1080_21645515_2018_1480236 crossref_primary_10_1016_j_vaccine_2019_09_039 crossref_primary_10_1186_s12889_020_09598_1 crossref_primary_10_7759_cureus_26337 crossref_primary_10_12688_f1000research_20079_1 crossref_primary_10_1136_practneurol_2020_002527 crossref_primary_10_1186_s12889_015_2621_5 |
Cites_doi | 10.1016/S0140-6736(12)61228-8 10.1016/j.vaccine.2014.01.081 10.1001/archpediatrics.2009.42 10.1503/cmaj.091820 10.1038/473443a 10.1016/j.vaccine.2014.10.011 10.1016/j.vaccine.2015.04.036 |
ContentType | Journal Article |
Contributor | MacDonald, Noni Eskola, Juhani Larson, Heidi Reingold, Arthur Liang, Xiaofeng Dubé, Eve Goldstein, Susan Gellin, Bruce Manzo, Mahamane Laouali Tshering, Kinzang Zhou, Yuqing Chaudhuri, Mohuya Duclos, Philippe Schuster, Melanie Hickler, Ben Guirguis, Sherine Butler, Robb |
Contributor_xml | – sequence: 1 givenname: Juhani surname: Eskola fullname: Eskola, Juhani – sequence: 2 givenname: Xiaofeng surname: Liang fullname: Liang, Xiaofeng – sequence: 3 givenname: Mohuya surname: Chaudhuri fullname: Chaudhuri, Mohuya – sequence: 4 givenname: Eve surname: Dubé fullname: Dubé, Eve – sequence: 5 givenname: Bruce surname: Gellin fullname: Gellin, Bruce – sequence: 6 givenname: Susan surname: Goldstein fullname: Goldstein, Susan – sequence: 7 givenname: Heidi surname: Larson fullname: Larson, Heidi – sequence: 8 givenname: Noni surname: MacDonald fullname: MacDonald, Noni – sequence: 9 givenname: Mahamane Laouali surname: Manzo fullname: Manzo, Mahamane Laouali – sequence: 10 givenname: Arthur surname: Reingold fullname: Reingold, Arthur – sequence: 11 givenname: Kinzang surname: Tshering fullname: Tshering, Kinzang – sequence: 12 givenname: Yuqing surname: Zhou fullname: Zhou, Yuqing – sequence: 13 givenname: Robb surname: Butler fullname: Butler, Robb – sequence: 14 givenname: Philippe surname: Duclos fullname: Duclos, Philippe – sequence: 15 givenname: Sherine surname: Guirguis fullname: Guirguis, Sherine – sequence: 16 givenname: Ben surname: Hickler fullname: Hickler, Ben – sequence: 17 givenname: Melanie surname: Schuster fullname: Schuster, Melanie |
Copyright | 2015 Copyright © 2015. Published by Elsevier Ltd. Copyright Elsevier Limited Aug 14, 2015 |
Copyright_xml | – notice: 2015 – notice: Copyright © 2015. Published by Elsevier Ltd. – notice: Copyright Elsevier Limited Aug 14, 2015 |
CorporateAuthor | the SAGE Working Group on Vaccine Hesitancy SAGE Working Group on Vaccine Hesitancy |
CorporateAuthor_xml | – name: the SAGE Working Group on Vaccine Hesitancy – name: SAGE Working Group on Vaccine Hesitancy |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PQEST PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1016/j.vaccine.2015.04.038 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) ProQuest Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (Proquest) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database PML(ProQuest Medical Library) Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Research Library Prep AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | 4179 |
ExternalDocumentID | 3792627201 10_1016_j_vaccine_2015_04_038 25896376 S0264410X15005022 1_s2_0_S0264410X15005022 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Europe Bulgaria |
GeographicLocations_xml | – name: Europe – name: Bulgaria |
GrantInformation_xml | – fundername: World Health Organization grantid: 001 |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 0SF 123 1B1 1P~ 1RT 1~. 1~5 29Q 3V. 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABXDB ACDAQ ACGFO ACGFS ACIUM ACPRK ACRLP ADBBV ADEZE ADFRT ADMUD ADVLN AEBSH AEFWE AEKER AENEX AEVXI AEXOQ AFCTW AFJKZ AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGGSO AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PQQKQ PROAC PSQYO Q38 R2- RIG ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP ~G- 6I. AAFTH AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG HMCUK LCYCR QYZTP UKHRP CGR CUY CVF ECM EIF NPM AAYXX ACRPL CITATION 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c598t-3f2204a918853c9801d0d53c4f5e6eded834f3939cb2669cf5677cda2ac62e743 |
IEDL.DBID | 8C1 |
ISSN | 0264-410X |
IngestDate | Wed Dec 04 05:52:16 EST 2024 Wed Dec 04 01:37:23 EST 2024 Thu Oct 10 21:02:29 EDT 2024 Fri Dec 06 01:48:13 EST 2024 Sat Sep 28 08:23:14 EDT 2024 Fri Feb 23 02:26:54 EST 2024 Tue Oct 15 22:55:55 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 34 |
Keywords | Tailoring immunization programmes Vaccine hesitancy Communicable diseases Emergency planning Vaccine hesitancy interventions Noncommunicable diseases TIP |
Language | English |
License | http://creativecommons.org/licenses/by/3.0 Copyright © 2015. Published by Elsevier Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c598t-3f2204a918853c9801d0d53c4f5e6eded834f3939cb2669cf5677cda2ac62e743 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X15005022 |
PMID | 25896376 |
PQID | 1708139531 |
PQPubID | 105530 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1712770798 proquest_miscellaneous_1706207262 proquest_journals_1708139531 crossref_primary_10_1016_j_vaccine_2015_04_038 pubmed_primary_25896376 elsevier_sciencedirect_doi_10_1016_j_vaccine_2015_04_038 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X15005022 |
PublicationCentury | 2000 |
PublicationDate | 2015-08-14 |
PublicationDateYYYYMMDD | 2015-08-14 |
PublicationDate_xml | – month: 08 year: 2015 text: 2015-08-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2015 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Meeting of the Strategic Advisory Group of Experts on immunization (bib0100) 2014; 89 ETAGE Meeting Report 2011. [accessed 02.02.15]. PSI Delta Marketing Planning Process – 7 Steps. World Health Organization, Regional Office for Europe (bib0030) 2013 Bystrom, Lindstrand, Likhite, Butler, Emmelin (bib0080) 2014; 32 WHO Regional Office for Europe. Tailoring Immunization Programmes. Outputs of pilot implementation in Bulgaria. Marmot, Allen, Bell, Bloomer, Goldblatt (bib0020) 2012; 380 World Health Organization, Department of Mental Health & Substance Dependence (WHO/MSD/MDP). Behavioural Science Learning Modules. Issue date: 2000. WHO EURO Collaborative Project with Sweden: “Hard-To-Serve” populations with low vaccine coverage in Sweden. Leask (bib0015) 2011; 473 MacDonald, the SAGE Working Group on Vaccine Hesitancy (bib0005) 2015; 33 WHO Regional Office for Europe. Tailoring immunization programmes to reach underserved groups – the TIP approach. Betsch (bib0065) 2014 Development of a Guide to Tailoring Antimicrobial Resistance Strategies. Larson, Jarrett, Eckersberger, Smith, Paterson (bib0010) 2014; 32 Developing tailored solutions to increase influenza vaccination uptake among health care workers. PSI Social marketing evidence base. Opel, Diekema, Lee, Marcuse (bib0045) 2009; 163 Lasker, Macdonald, Hebert (bib0095) 2009; 181 Health Communication Capacity Collaborative. USAID. Understanding Formative Research: Methods, Management, and Ethics for Behaviour Change Communication. 10.1016/j.vaccine.2015.04.038_bib0050 10.1016/j.vaccine.2015.04.038_bib0060 Leask (10.1016/j.vaccine.2015.04.038_bib0015) 2011; 473 10.1016/j.vaccine.2015.04.038_bib0085 10.1016/j.vaccine.2015.04.038_bib0040 10.1016/j.vaccine.2015.04.038_bib0090 10.1016/j.vaccine.2015.04.038_bib0070 Bystrom (10.1016/j.vaccine.2015.04.038_bib0080) 2014; 32 10.1016/j.vaccine.2015.04.038_bib0025 Opel (10.1016/j.vaccine.2015.04.038_bib0045) 2009; 163 10.1016/j.vaccine.2015.04.038_bib0035 Betsch (10.1016/j.vaccine.2015.04.038_bib0065) 2014 Meeting of the Strategic Advisory Group of Experts on immunization (10.1016/j.vaccine.2015.04.038_bib0100) 2014; 89 10.1016/j.vaccine.2015.04.038_bib0075 World Health Organization (10.1016/j.vaccine.2015.04.038_bib0030) 2013 Larson (10.1016/j.vaccine.2015.04.038_bib0010) 2014; 32 10.1016/j.vaccine.2015.04.038_bib0055 Lasker (10.1016/j.vaccine.2015.04.038_bib0095) 2009; 181 MacDonald (10.1016/j.vaccine.2015.04.038_bib0005) 2015; 33 Marmot (10.1016/j.vaccine.2015.04.038_bib0020) 2012; 380 |
References_xml | – volume: 89 start-page: 561 year: 2014 end-page: 576 ident: bib0100 article-title: Conclusions and recommendations publication-title: Wkly Epidemiol Rec contributor: fullname: Meeting of the Strategic Advisory Group of Experts on immunization – volume: 33 start-page: 4161 year: 2015 end-page: 4164 ident: bib0005 article-title: Vaccine Hesitancy Definition, Scope and Determinants publication-title: Vaccine contributor: fullname: the SAGE Working Group on Vaccine Hesitancy – year: 2013 ident: bib0030 article-title: The Guide for Tailoring Immunization Programs. Increasing coverage of infant and child vaccination in the WHO European Region contributor: fullname: Regional Office for Europe – volume: 32 start-page: 6752 year: 2014 end-page: 6757 ident: bib0080 article-title: Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden – a qualitative study publication-title: Vaccine contributor: fullname: Emmelin – volume: 163 start-page: 432 year: 2009 end-page: 437 ident: bib0045 article-title: Social marketing as a strategy to increase immunization rates publication-title: Arch Pediatr Adolesc Med contributor: fullname: Marcuse – year: 2014 ident: bib0065 article-title: Commentary: success and future of the TIP approach publication-title: TIP Orientation Workshop June 2014 contributor: fullname: Betsch – volume: 473 start-page: 443 year: 2011 end-page: 445 ident: bib0015 article-title: Target the fence-sitters publication-title: Nature contributor: fullname: Leask – volume: 380 start-page: 1011 year: 2012 end-page: 1029 ident: bib0020 article-title: WHO European review of social determinants of health and the health divide publication-title: Lancet contributor: fullname: Goldblatt – volume: 32 start-page: 2150 year: 2014 end-page: 2159 ident: bib0010 article-title: Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012 publication-title: Vaccine contributor: fullname: Paterson – volume: 181 start-page: 661 year: 2009 ident: bib0095 article-title: Fixing the fatal flaw in emergency planning publication-title: CMAJ contributor: fullname: Hebert – year: 2013 ident: 10.1016/j.vaccine.2015.04.038_bib0030 contributor: fullname: World Health Organization – ident: 10.1016/j.vaccine.2015.04.038_bib0040 – volume: 89 start-page: 561 issue: October year: 2014 ident: 10.1016/j.vaccine.2015.04.038_bib0100 article-title: Conclusions and recommendations publication-title: Wkly Epidemiol Rec contributor: fullname: Meeting of the Strategic Advisory Group of Experts on immunization – ident: 10.1016/j.vaccine.2015.04.038_bib0090 – ident: 10.1016/j.vaccine.2015.04.038_bib0070 – ident: 10.1016/j.vaccine.2015.04.038_bib0050 – ident: 10.1016/j.vaccine.2015.04.038_bib0085 – volume: 380 start-page: 1011 issue: September (9846) year: 2012 ident: 10.1016/j.vaccine.2015.04.038_bib0020 article-title: WHO European review of social determinants of health and the health divide publication-title: Lancet doi: 10.1016/S0140-6736(12)61228-8 contributor: fullname: Marmot – year: 2014 ident: 10.1016/j.vaccine.2015.04.038_bib0065 article-title: Commentary: success and future of the TIP approach contributor: fullname: Betsch – volume: 32 start-page: 2150 issue: April (19) year: 2014 ident: 10.1016/j.vaccine.2015.04.038_bib0010 article-title: Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012 publication-title: Vaccine doi: 10.1016/j.vaccine.2014.01.081 contributor: fullname: Larson – volume: 163 start-page: 432 issue: May (5) year: 2009 ident: 10.1016/j.vaccine.2015.04.038_bib0045 article-title: Social marketing as a strategy to increase immunization rates publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpediatrics.2009.42 contributor: fullname: Opel – ident: 10.1016/j.vaccine.2015.04.038_bib0055 – volume: 181 start-page: 661 issue: November (10) year: 2009 ident: 10.1016/j.vaccine.2015.04.038_bib0095 article-title: Fixing the fatal flaw in emergency planning publication-title: CMAJ doi: 10.1503/cmaj.091820 contributor: fullname: Lasker – volume: 473 start-page: 443 issue: May (7348) year: 2011 ident: 10.1016/j.vaccine.2015.04.038_bib0015 article-title: Target the fence-sitters publication-title: Nature doi: 10.1038/473443a contributor: fullname: Leask – ident: 10.1016/j.vaccine.2015.04.038_bib0035 – ident: 10.1016/j.vaccine.2015.04.038_bib0060 – ident: 10.1016/j.vaccine.2015.04.038_bib0025 – ident: 10.1016/j.vaccine.2015.04.038_bib0075 – volume: 32 start-page: 6752 issue: November (50) year: 2014 ident: 10.1016/j.vaccine.2015.04.038_bib0080 article-title: Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden – a qualitative study publication-title: Vaccine doi: 10.1016/j.vaccine.2014.10.011 contributor: fullname: Bystrom – volume: 33 start-page: 4161 issue: 34 year: 2015 ident: 10.1016/j.vaccine.2015.04.038_bib0005 article-title: Vaccine Hesitancy Definition, Scope and Determinants publication-title: Vaccine doi: 10.1016/j.vaccine.2015.04.036 contributor: fullname: MacDonald |
SSID | ssj0005319 |
Score | 2.6035786 |
Snippet | Abstract Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from... Despite relatively high vaccination coverage rates in the European Region, vaccine hesitancy is undermining individual and community protection from vaccine... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4176 |
SubjectTerms | Allergy and Immunology Behavior Caregivers Children & youth Communicable diseases Emergency planning Emergency preparedness Europe Health Knowledge, Attitudes, Practice Humans Immunization Immunization Programs - methods Intervention Mothers Noncommunicable diseases Patient Acceptance of Health Care Patient Compliance Population Romani people Social marketing Socioeconomic factors Tailoring immunization programmes TIP Treatment Refusal Vaccination Vaccine hesitancy Vaccine hesitancy interventions Vaccines World Health Organization |
SummonAdditionalLinks | – databaseName: Elsevier Medicine Collection dbid: AIKHN link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF9qi-KL6Pl1WmUEKQpNL7dJNolvpVrvlJYDr3Jvy2azwRSaK82dUPCPd2Z3c1H8At_yscNusrMzk-zvN8PYS81zXgn6_4UfX0EcqTLIitgEVcopw5PItS3fdnIqJmfxh0Wy2GJHHReGYJXe9jubbq21vzLyb3N0WdejT6H15eECQ5owQVd0g-2gO6K92p3D6cfJaY_0iGx9D2ofkEBP5BmdH3xVmnawCeSV2KSnxFT5vYv6UwhqXdHxXXbHx5Bw6IZ5j22ZZsBuuqqS1wN268Tvlw_Y3sxlpr7eh3lPtGr3YQ9mfc5qlBl8JliM5eZCJ36ffXvrgHjo3gADRSh_wM7AsgL_VPCFiguQmYa6AeJuEv4I2nVhOSPtG-oc3q_r0sBqCXNVO9gfTC05xRFBYeaQYhemhVfz6ez1A3Z2_G5-NAl8uYZAJ3m2CqKK8zBW-TjDEEDn6PrKsMSjuEqMMKUpsyiuojzKdYFRQa6rRKSpLhVXWnCDkcxDtt0sG_OYga70mPgJUVJSTjJV8JTEI21EoTJVDdlBN0Py0mXlkB1c7Vz6h5c0pTKMJU7pkKXdPMqOcopG0rR-xbZyLFsuQ_mLVg1ZtpH8STEl-px_dbrbaYzs-0kxCIty1Mkhe7G5jWuaNmpUY5Zr20bwMOWC_63NmKeU3hC7eeS0cfMqeJKhXU3Fk_8f-1N2m87o7_k43mXbq6u1eYbh16p47pfXdzJOLeU priority: 102 providerName: Elsevier |
Title | Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP) |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X15005022 https://dx.doi.org/10.1016/j.vaccine.2015.04.038 https://www.ncbi.nlm.nih.gov/pubmed/25896376 https://www.proquest.com/docview/1708139531 https://search.proquest.com/docview/1706207262 https://search.proquest.com/docview/1712770798 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fb9MwELbYJhAvCMqvwqiMhCaQli5xnDjhBY2x0YJWRdChvFmJ44hOIhmkRZqE-Nu5s512DzBe0kiJ5aRn332xv--OkBeKpayOcf0LPr48HhaVl5Rce7VgmOEpTpUp33Y6iydn_EMe5W7BrXO0yt4nGkddtQrXyA8CAcErTGHIvLn47mHVKNxddSU0tshOgIEOleJHVygeoSnsAZ8Z3OOBn28UPAfn45-Fwq1rZHdFJtspSlT-Hpv-hT1NDDq5S-448EgPrbXvkRu6GZCbtpzk5YDcOnUb5QOyl9mU1Jf7dL5RWHX7dI9mm2TV0GbwBfkwRpRL--b3ya93loEHcY0CQqTVFdIMbWvq3op-xaoC6J_poqEo2kTiEe1WpRGLdK-xc_p-tag0XbZ0Xiws349OjSrFKkBpZili33RHX86n2asH5OzkeH408VydBk9FabL0wpoxnxdpkEDsVynEvMqv4IzXkY51pask5HWYhqkqAQ6kqo5iIVRVsELFTAOEeUi2m7bRjwlVtQpQmBBGFSYjK0omsHmodFwWSVEPybi3kLyw6Thkz1M7l-7lJZpU-lyCSYdE9HaUvdYUvKPu3FTtZCA7Jn352TfQ0M8BIfsRIJshSdYtHRqxKENCsPlfp7v9iJGbftYDeEiery_DZMYdmqLR7crcEzNfsJhdd0_ABOY1hG4e2dG4_itYlIBDFfGT6x_gKbmNT4tL4wHfJdvLHyv9DLDVshyRrfHvAI4iFyMzmUZk53D6cTKD37fHs-zTHzPuJ0E |
link.rule.ids | 314,780,784,4502,12056,12223,21388,24116,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,45585,45679,73745,74014,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLagE5cXBOVWGGAkNIG0bInjOAkviMtGC2tVQYb6ZjmOo3XSkkFapEn8eM5xnIYHGG-REstOjn3OF_v7ziHkhWYpKwXuf8HPl8dDVXhJzo1XxgwzPIlU2_Jt05kYH_NPi2jhNtwaR6vsfKJ11EWtcY98P4gheIUpTJk35989rBqFp6uuhMZVsoWZ06MB2Xp3MJt_6UkeoS3tAT8a3OOBv-g1PPunez-VxsNr5HdFNt8pilT-Hp3-hT5tFDq8TW45-Ejftva-Q66YakiutQUlL4bk-tQdlQ_JzrxNSn2xS7NeY9Xs0h0679NVQ5vhN2TEWFku7ZrfJb8-tBw8iGwUMCIt_qDN0Lqk7q3oCdYVQA9NlxVF2SZSj2izzq1cpHmNndOP62Vh6KqmmVq2jD86sbqUVgNK5y1J7Mw09GU2mb-6R44PD7L3Y89VavB0lCYrLywZ87lKgwSiv04h6hV-AVe8jIwwhSmSkJdhGqY6B0CQ6jIScawLxZQWzACIuU8GVV2Zh4TqUgcoTQijAtORqZzF2DzURuQqUeWI7HUWkudtQg7ZMdVOpXt5iSaVPpdg0hGJOzvKTm0K_tE0brE2MpANk7786ltw6C8AI_sRYJsRSTYtHR5pcYaEcPO_Tre7GSP7fjZTeESeb27DcsYzGlWZem2fEcyPmWCXPROwGDMbQjcP2tm4-RQsSsClxuLR5QN4Rm6Ms-mRPJrMPj8mN3HkuFEe8G0yWP1YmyeAtFb5U7ecfgNOxCbC |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fb9MwELagExMvCMqvwgAjoQmkZXWc37wgYCsrsCqCDvXNcmxH66Qlg7RIk_jjuXOchgcYb5ESy07Ovvtif98dIS8Uz3gZ4_4X_Hx5YSC1lxah8cqEY4anOFO2fNvxLD46CT8uooXjPzWOVtn5ROuoda1wj3zsJxC8ggymzLh0tIj8YPLm4ruHFaTwpNWV07hOtiAqMj4gW-8OZ_mXnvAR2DIf8NMReqHPFr2eZ3y2_1MqPMhGrldkc5-iYOXvkepfSNRGpMltcstBSfq2tf0dcs1UQ3KjLS55OSTbx-7YfEh28zZB9eUenfd6q2aP7tK8T10NbYbfkB1jJbq0a36X_Dpo-XgQ5SjgRar_oNDQuqTuregp1hhAb02XFUUJJ9KQaLMurHSkeY2d0w_rpTZ0VdO5XLbsPzq1GpVWD0rzljB2bhr6cj7NX90jJ5PD-fsjz1Vt8FSUpSsvKDlnocz8FJCAyiACaqbhKiwjExttdBqEZZAFmSoAHGSqjOIkUVpyqWJuwHT3yaCqK_OQUFUqH2UKQaQxNZkseILNA2XiQqayHJH9zkLiok3OITrW2plwLy_QpIKFAkw6IklnR9EpT8FXmsYt3Eb4ouGCia_MAkW2ALzMIsA5I5JuWjps0mIOAaHnf53udDNG9P1spvOIPN_chqWN5zWyMvXaPhNzlvCYX_WMzxPMcgjdPGhn4-ZT8CgF95rEj64ewDOyDStJfJ7OPj0mN3HguGfuhztksPqxNk8AdK2Kp241_QYfFirv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosing+the+determinants+of+vaccine+hesitancy+in+specific+subgroups%3A+The+Guide+to+Tailoring+Immunization+Programmes+%28TIP%29&rft.jtitle=Vaccine&rft.au=Butler%2C+Robb&rft.au=MacDonald%2C+Noni+E&rft.date=2015-08-14&rft.eissn=1873-2518&rft.volume=33&rft.issue=34&rft.spage=4176&rft_id=info:doi/10.1016%2Fj.vaccine.2015.04.038&rft_id=info%3Apmid%2F25896376&rft.externalDocID=25896376 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X15X0034X%2Fcov150h.gif |